Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
9.72
-0.04 (-0.41%)
At close: Oct 13, 2025, 4:00 PM EDT
9.90
+0.18 (1.85%)
After-hours: Oct 13, 2025, 7:50 PM EDT
Nurix Therapeutics Revenue
Nurix Therapeutics had revenue of $7.89M in the quarter ending August 31, 2025, a decrease of -37.29%. This brings the company's revenue in the last twelve months to $83.69M, up 48.32% year-over-year. In the fiscal year ending November 30, 2024, Nurix Therapeutics had annual revenue of $54.55M, down -29.15%.
Revenue (ttm)
$83.69M
Revenue Growth
+48.32%
P/S Ratio
9.58
Revenue / Employee
$292,612
Employees
286
Market Cap
747.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 54.55M | -22.44M | -29.15% |
Nov 30, 2023 | 76.99M | 38.36M | 99.31% |
Nov 30, 2022 | 38.63M | 8.88M | 29.84% |
Nov 30, 2021 | 29.75M | 11.93M | 66.95% |
Nov 30, 2020 | 17.82M | -13.30M | -42.73% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NRIX News
- 2 days ago - Nurix: Bexobrutideg Advancement Presses Forward With H2 2025 Milestones - Seeking Alpha
- 4 days ago - Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 26 days ago - Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis - GlobeNewsWire
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript - Seeking Alpha
- 4 weeks ago - Nurix Therapeutics, Inc. (NRIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire